Back in 2010, Clarkston introduced our Speed & Agility Index, which identified that consumers are becoming hard to predict, making ...

For the second time in less than 10 years, McKesson Corporation (NSE:MCK) is paying a multimillion dollar fine for not ...

In addition to working with some of the most innovative companies in the life sciences industry, one of the greatest ...

The FDA's Plan to Transform & Evolve Through Data

Facing the Quality Management Challenges for Medical Device Companies

Every year patents for branded drugs continue to expire and with each expiration, the generics market expands ever larger. As the market ...

As pharmaceutical companies introduce new therapies to the U.S. market, they respond to risk-sharing agreements (RSAs) from healthcare providers, which ...

The 2.3 percent excise tax on medical devices has been one of the more publicly controversial inclusions in the five-year-old ...

The Department of Homeland Security is currently investigating dozens of cybersecurity cases related to medical devices and their potential for ...

The first post in the Analytics in Life Sciences blog series covered New Product Development. Today, we will look at ...

Clarkston Consulting attended the Generic Pharmaceutical Association (GPhA) Annual Meeting earlier this month in Miami, Florida. This annual meeting is the ...

Requirements and Implications for the Pharmaceutical Industry